Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

North American Prodromal Synucleinopathy Consortium

NCT03623672 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03623672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03623672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
North American Prodromal Synucleinopathy Consortium
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 29, 2018
Completion date
July 31, 2026
Enrollment
500 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies, lewy body disease, multiple system atrophy, parkinson disease, rem sleep behavior disorder, rem sleep parasomnias